Tirzepatide injection guide: where and how to inject the pen

Tirzepatide is a once-weekly injection you give yourself under the skin — not into a vein or muscle. It’s the same molecule whether your box says Zepbound or Mounjaro, and it usually comes as a single-dose auto-injector: one pen holds one week’s dose. Some people are prescribed single-dose vials drawn with a syringe instead. Below is where the injection goes, how the technique works step by step, and the storage and disposal rules that keep it safe.

Where to inject tirzepatide

Tirzepatide goes into subcutaneous fat — the soft layer just under the skin — at one of three sites (⚠ verify descriptions against the Instructions for Use):

• Abdomen (belly) — the most common spot. Stay at least 2 inches away from your navel in any direction. Most people find the stomach the easiest area to see and reach.
• Front of the thigh — the fleshy area on the top and slightly outer part of the upper leg, between hip and knee.
• Back of the upper arm — the fatty area behind and below the shoulder. It’s the hardest to reach yourself, so many people save it for when someone can help.

All three absorb the medicine equally well, so choice comes down to comfort and reach. Whichever area you pick, avoid skin that’s bruised, tender, hard, lumpy, scarred, or red. And rotate — repeatedly injecting the same patch can build up lipohypertrophy, thickened fatty lumps that make future doses absorb unevenly. More on the rotation pattern below.

How to inject tirzepatide step by step

This is the general once-weekly technique for the tirzepatide single-dose auto-injector. Your printed Instructions for Use is the authority on the details specific to your device — read it the first time, and keep it for reference.

1. Wash your hands with soap and water, and gather your pen, an alcohol swab, and a sharps container.
2. Inspect the pen and medicine. Check the label and the name on the box, and look through the viewing window — the liquid should be clear and colorless to slightly yellow. Don’t use it if it’s cloudy, discolored, or has particles, or if the pen is cracked or past its expiry.
3. Let it reach room temperature. Injecting straight from the fridge stings more; many people take the pen out a little ahead of time (⚠ verify any timing against the IFU). Never warm it in a microwave or hot water, and never shake it.
4. Pick and clean a spot. Choose one of the three sites, wipe it with the alcohol swab, and let it dry fully — injecting through wet alcohol is what stings.
5. Uncap the pen. Pull the cap straight off; don’t put it back on. Don’t touch the needle end.
6. Press it flat against your skin and inject. Hold the base flat against the cleaned site and press down to unlock, then hold. You’ll hear a first click as the injection starts and a second click when it’s done — keep holding steady until it finishes (⚠ verify the hold and click sequence against the IFU). If you use vials instead, draw your prescribed dose with the syringe and inject at the angle your IFU shows.
7. Lift straight up. Once the injection is complete, lift the pen away from your skin. A small drop of blood or slight bruising is normal; press gently with gauze rather than rubbing.
8. Dispose of the used pen straight into your sharps container. The auto-injector is single-use — never recap it and never reuse it.

Because tirzepatide is prescribed for weight loss (Zepbound) or type 2 diabetes (Mounjaro), that use — like every dosing decision — stays directed by your clinician. The technique on this page is the same either way; the dose and the plan are not something to self-adjust.

Rotating injection sites

Rotating does one job: it protects your skin. Inject the same square inch week after week and the tissue can thicken into lipohypertrophy — firm, rubbery lumps that both look different and absorb medicine less predictably, which can make your dose work less reliably.

A simple rotation that’s easy to remember:

• Rotate between areas across weeks — for example, abdomen one week, thigh the next, upper arm the week after, then back to the abdomen.
• Rotate within an area too. If you use the abdomen two weeks in a row, shift the exact spot by at least an inch, and switch sides of the navel.
• Keep a simple log — a note on your phone or a mark on a calendar — so you’re not guessing where last week’s injection went.

The abdomen has the most usable real estate, which is why many people anchor there and just keep moving the spot around it. Whatever pattern you choose, the principle is the same: never two injections in the same place back to back.

Storing tirzepatide

Storage matters because heat and freezing both ruin tirzepatide. General guidance (⚠ verify every temperature and day figure against the label at pi.lilly.com/us/zepbound-uspi.pdf):

• Before first use: keep pens or vials in the refrigerator at 36–46°F (⚠ verify). Don’t store them near the freezer coils.
• Unrefrigerated: if needed, tirzepatide can be kept at room temperature up to 86°F for up to 21 days (⚠ verify window) — then discard it even if medicine remains.
• Never freeze it. A pen or vial that has been frozen is ruined and must be thrown away, even if it looks fine (⚠ verify).
• Traveling: keep it cool and out of direct sun — a cool bag without a frozen pack touching the pen. Don’t leave it in a hot car or checked luggage.
• Always store it in its original carton to protect it from light, away from heat, and out of reach of children.

Needles and sharps disposal

Every injection uses a new, single-use device — one auto-injector per weekly dose, or a fresh needle for every vial injection. A single-use pen is never reused and never shared, and a fresh needle is sharper, hurts less, and avoids the infection and blockage risks a dull, reused one carries.

Used pens and needles are biohazard sharps and can’t go in household trash or recycling. Handle them this way:

• Drop each used pen or needle straight into an FDA-cleared sharps disposal container — a rigid, puncture-resistant, lidded container made for the purpose.
• If you don’t have one on hand, a heavy-duty plastic container with a tight screw-on lid can work as a temporary stand-in, but a proper sharps container is the right tool.
• Don’t overfill it, don’t recap needles by hand, and when it’s about three-quarters full, seal and dispose of it following your local guidelines — programs vary by state and city.

The FDA’s sharps guidance (linked in Sources) explains local disposal options, from drop-off sites to mail-back programs.

Common mistakes and when to call your clinician

A few errors come up again and again:

• Injecting into muscle instead of fat. Tirzepatide is subcutaneous. The auto-injector is built to deposit into the fat layer when pressed flat; if you use vials and a syringe, going in too deep — wrong angle, or a very lean spot with a long needle — can sting more and change absorption. Pinching a fold of skin helps if you’re lean.
• Lifting the pen too early, before both clicks finish, which can leave part of the dose on your skin.
• Reusing a device. One new pen or needle per dose, every time.
• Not rotating sites, which invites the lumps described above.
• A missed dose. There’s a specific rule for how long a window you have to take it late versus skip it — don’t guess, and never double up. Our missed-dose helper walks you through it.

Mild, short-lived redness, itching, or a small bump at the injection site is common and usually fades on its own. What deserves a call to your clinician: a site reaction that spreads, worsens, or doesn’t settle; signs of infection like increasing pain, warmth, or pus; or any symptom that feels bigger than the injection itself — a rash all over, swelling of the face or throat, trouble breathing, or severe belly pain that won’t go away. Those are not “inject through it” symptoms. When in doubt, see GLP-1 safety and contact your prescriber.